Obalon Therapeutics Inc. | Ownership

Companies that own Obalon Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Tamarack Advisers LP
1,050,000
5.89%
625,000
0.89%
06/30/2018
The Vanguard Group, Inc.
435,341
2.44%
-18,232
0%
06/30/2018
Level Four Advisory Services LLC
330,427
1.86%
0
0.07%
06/30/2018
C WorldWide Asset Management Fondsmæglerselskab A/S
315,790
1.77%
67,746
0.01%
06/30/2018
C Worldwide Asset Management Fondsmæglerselskab A/S (Sweden)
315,504
1.77%
-9,758
0.07%
08/31/2018
HighTower Advisors LLC
126,288
0.71%
0
0%
06/30/2018
Millennium Management LLC
82,333
0.46%
67,382
0%
06/30/2018
Tiverton Asset Management LLC
66,807
0.38%
-8,200
0.01%
06/30/2018
Renaissance Technologies LLC
56,700
0.32%
42,100
0%
06/30/2018
Fred Alger Management, Inc.
46,795
0.26%
0
0%
06/30/2018

About Obalon Therapeutics

View Profile
Address
5421 Avenida Encinas
Carlsbad California 92008
United States
Employees -
Website http://www.obalon.com
Updated 07/08/2019
Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated. The company was founded in January 2008 and is headquartered in San Diego, CA.